To which one of the following groups would it be acceptable to give a live attenuated viral vaccine?
Show Hint
Live attenuated vaccines (like MMR, Varicella, and Rotavirus) are contraindicated in pregnant women and immunocompromised individuals due to the risk of uncontrolled viral replication. These groups should receive inactivated or subunit vaccines instead.
Step 1: Understanding the Concept:
Live attenuated vaccines contain wild-type viruses that have been weakened (attenuated) through repeated passage in cell cultures or non-human hosts.
These attenuated viruses can replicate and stimulate a strong, long-lasting immune response, but they do not cause disease in healthy individuals. Step 2: Detailed Explanation:
Because live attenuated vaccines contain active, replicating viruses, their safety depends on the host's immune system being able to control and clear the viral infection.
If a live attenuated vaccine is given to an immunocompromised individual, the weakened virus can replicate unchecked.
This uncontrolled replication can cause severe, life-threatening systemic disease.
Let us evaluate the patient groups listed in the options:
- Patients undergoing radiotherapy (Option A) and patients with leukemia (Option C) have severely compromised immune systems due to the destruction of white blood cells. Giving them a live vaccine is contraindicated.
- Pregnant mothers (Option B) should not receive live attenuated vaccines because the replicating virus can cross the placenta and infect the developing fetus, potentially causing congenital defects or miscarriage.
- Healthy children under 8 years of age (Option D) have mature, active immune systems capable of safely processing the attenuated virus.
In fact, many standard childhood vaccines (such as the Measles, Mumps, and Rubella (MMR) vaccine and the Oral Polio Vaccine (OPV)) are live attenuated vaccines routinely administered to children in this age group to establish long-term immunity. Step 3: Final Answer:
It is safe and acceptable to administer live attenuated viral vaccines to children under 8 years of age.
